The MASLD group had a decrease in IL-10, IL-23, CXCL10 and TGF-β1, while in the non-MASLD group, there was a decrease in IFN-γ, IL-6, IL-23 and CCL20 (Figure 1 and Figure 2). This evidence concerns the gene CCL20 and metabolic dysfunction-associated steatotic liver disease.